Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics (CRTPF)

Cardiol Therapeutics (CRTPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cannabidiol Phase 1 Clinical Trial Launches, Targeting Inflammatory Heart Condition -- SECFilings.com

Redondo Beach, California--(Newsfile Corp. - September 16, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

Oakville, Ontario--(Newsfile Corp. - September 15, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - August 26, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Global Pandemic Creating Opportunities for Drug Companies to Earn Positive Market Attention

, /PRNewswire/ -- In the last 18 years, viral disease epidemics have across the globe. Today's pandemic is quickly adding to the number of deaths while seriously disrupting economies, businesses, and...

GILD : 63.09 (-0.49%)
AZN : 55.66 (+0.40%)
PFE : 36.00 (-0.69%)
LLY : 149.81 (-0.03%)
CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Orphan Drug Designation Is Proven Path for CBD -- SECFilings.com

Redondo Beach, California--(Newsfile Corp. - August 5, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor

Oakville, Ontario--(Newsfile Corp. - June 29, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
David Elsley Files Early Warning Report for Cardiol Therapeutics

Oakville, Ontario--(Newsfile Corp. - June 25, 2020) - () () ("" or the ""), today announced that David Elsley, President and CEO of Cardiol, has filed an early warning report (the "Report") in respect...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option

Oakville, Ontario--(Newsfile Corp. - June 4, 2020) - () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRTPF : 1.8800 (-9.51%)
CRDL.TO : 2.48 (-10.14%)
Cardiol Therapeutics Reports 2020 AGM Results

Oakville, Ontario--(Newsfile Corp. - June 2, 2020) - ( () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT

Oakville, Ontario--(Newsfile Corp. - May 29, 2020) - ( () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering

Oakville, Ontario--(Newsfile Corp. - May 14, 2020) - Cardiol Therapeutics Inc. ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering

Oakville, Ontario--(Newsfile Corp. - May 13, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19

Oakville, Ontario--(Newsfile Corp. - May 6, 2020) - Cardiol Therapeutics Inc. () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart

Oakville, Ontario--(Newsfile Corp. - April 14, 2020) -  () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure

Oakville, Ontario--(Newsfile Corp. - April 1, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A

Oakville, Ontario--(Newsfile Corp. - March 26, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Hemp's Resurgence Continues as the FDA Hones in on CBD

CBD has garnered a strong reputation for its wide range of potential health benefits. However, it has only been approved to treat childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut...

IIPR : 118.13 (-5.19%)
CRTPF : 1.8800 (-9.51%)
CRDL.TO : 2.48 (-10.14%)
TLRY : 4.70 (-12.40%)
CRON : 5.05 (-4.90%)
OGI : 1.1100 (-6.72%)
Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.

Oakville, Ontario--(Newsfile Corp. - March 18, 2020) - () ()(""or the""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation

Oakville, Ontario--(Newsfile Corp. - March 5, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics' Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

Oakville, Ontario--(Newsfile Corp. - January 15, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar